News & Updates

Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.

A moderate increase in the consumption of foods rich in isoflavone can help reduce the risk of lung cancer in women with no smoking history, suggests a study.

Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.

Patients with asthma or chronic obstructive pulmonary disease (COPD) may be at a higher risk of chronic otitis media, reports a recent study.